Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: A real-life survey in Spain

被引:29
|
作者
Gisbert, J. P. [1 ]
Gomollon, F. [2 ]
Hinojosa, J. [3 ]
Lopez San Roman, A. [4 ]
机构
[1] Hosp Univ La Princesa, Dept Gastroenterol, Madrid, Spain
[2] Hosp Clin Univ Zaragoza, Dept Gastroenterol, Zaragoza, Spain
[3] Hosp Manises, Dept Gastroenterol, Valencia, Spain
[4] Hosp Ramon & Cajal, Dept Gastroenterol, E-28034 Madrid, Ibdnet, Spain
来源
JOURNAL OF CROHNS & COLITIS | 2010年 / 4卷 / 05期
关键词
Ulcerative colitis; ECCO clinical guidelines; Inflammatory bowel disease; 5; ASA; Mesalazine; Questionnary; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; COLORECTAL-CANCER; MESALAZINE; THERAPY; NONADHERENCE; METAANALYSIS; MANAGEMENT; MESALAMINE;
D O I
10.1016/j.crohns.2010.06.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & aims A European consensus on the management of ulcerative colitis (UC) was recently published, however, there is no adequate evidence about adherence to such guidelines among gastroenterologists This knowledge would allow the local evaluation of the situation and the adoption of actions to reduce the existent clinical variability Methods A cross sectional survey was conducted in Spain to assess the adherence to the European Crohn s and Colitis Organisation (ECCO) guidelines on mild to moderate UC We surveyed 700 gastroenterologists, and finally a total of 530 gastroenterologists specialised in inflammatory bowel disease (GSIBDs) and general gastroenterologists (GGs), responded to the survey (76%) Results Agreement with the guidelines was high, discrepancies included that only 25% of the GGs used the combination of oral and topical 5 aminosalycilic acid (5 ASA) for treating extensive UC vs 45% of the GISBDs In addition, topical rectal steroids were considered as effective as topical mesalazine by 48% of the GGs vs 31% of the GSIBDs, indefinite treatment with 5 ASA was prescribed by only 26% of the GGs vs 41% of the GSIBDs, and the once daily dosing of 5 ASA was generally used by 46% of the GGs vs 51% of the GSIBDs Conclusions The questionnaire showed a high degree of agreement between GGs and GSIBDs Nevertheless, the GSIBD group showed closer agreement with the ECCO guidelines Furthermore, some shortcomings were found in the GG group, in which increased maintenance treatment with 5 ASA, the use of a single daily dose of 5 ASA, and the use of combined oral and topical treatment for distal colitis should be advised (C) 2010 European Crohn s and Colitis Organisation Published by Elsevier B V All rights reserved
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [1] Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain
    Hinojosa, J.
    Gisbert, J. P.
    Gomollon, F.
    San Roman, A. Lopez
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (07): : 763 - 770
  • [2] Vedolizumab: Real-life outcomes to therapy in ulcerative colitis
    Pulusu, S. S. R.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Parthasarathy, N.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q-U-A
    Taylor, K.
    Sewell, K.
    Cooke, S.
    Mahy, G.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Lawrance, I.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 142 - 142
  • [3] Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
    Klepp, Pasquale
    Tollisen, Anita
    Roseth, Arne
    Smastuen, Milada Cvancarova
    Andersen, Solveig N.
    Vatn, Morten
    Moum, Bjorn A.
    Brackmann, Stephan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (35) : 4069 - 4076
  • [4] Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
    Pasquale Klepp
    Anita Tollisen
    Arne R?seth
    Milada Cvancarova Sm?stuen
    Solveig N Andersen
    Morten Vatn
    Bj?rn A Moum
    Stephan Brackmann
    [J]. World Journal of Gastroenterology, 2018, 24 (35) : 4069 - 4076
  • [5] REAL-LIFE DOSE ESCALATION OF PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE UNDERGOING BIOLOGIC TREATMENT IN PORTUGAL
    Lopes da Cruz, J. P.
    Faria, M.
    Aleixo, A. S.
    Pereira, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S533 - S533
  • [6] Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations
    Peyrin-Biroulet, Laurent
    Loennfors, Sanna
    Roblin, Xavier
    Danese, Silvio
    Avedano, Luisa
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (01): : 128 - 133
  • [7] What is the real-life maintenance mesalazine dose in ulcerative colitis?
    Algaba, Alicia
    Guerra, Ivan
    Garcia-Garcia-de-Paredes, Ana
    Hernandez-Tejero, Maria
    Ferre, Carlos
    Bonillo, Daniel
    Aguilera, Lara
    Lopez-Sanroman, Antonio
    Bermejo, Fernando
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (02) : 114 - 121
  • [8] Adalimumab in Active Ulcerative Colitis: A "Real-Life" Observational Study
    Armuzzi, Alessandro
    Biancone, Livia
    Daperno, Marco
    Coli, Alessandra
    Annese, Vito
    Ardizzone, Sandro
    Balestrieri, Paola
    Bossa, Fabrizio
    Castiglione, Fabiana
    Cicala, Michele
    Danese, Silvio
    D'Inca, Renata
    Dulbecco, Pietro
    Feliciangeli, Giuseppe
    Fries, Walter
    Genise, Stefania
    Gionchetti, Paolo
    Gozzi, Stefano
    Kohn, Anna
    Lorenzetti, Roberto
    Milla, Monica
    Onali, Sara
    Papi, Claudio
    Papparella, Luigi Giovanni
    Pugliese, Daniela
    Renna, Sara
    Ricci, Chiara
    Rizzello, Fernando
    Sostegni, Raffaello
    Guidi, Luisa
    Orlando, Ambrogio
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S350 - S351
  • [9] Is the European Crohn's and Colitis organisation (ECCO) e-guide an acceptable and feasible tool for increasing gastroenterologists' guideline adherence? A mixed methods evaluation
    Kanazaki, Ria
    Smith, Ben
    Bu, Stella
    Girgis, Afaf
    Connor, Susan J.
    [J]. BMC MEDICAL EDUCATION, 2024, 24 (01)
  • [10] Real-life evaluation of histologic scores for Ulcerative Colitis in remission
    Arkteg, Christian Borde
    Sorbye, Sveinung Wergeland
    Riis, Lene Buhl
    Dalen, Stig Manfred
    Florholmen, Jon
    Goll, Rasmus
    [J]. PLOS ONE, 2021, 16 (03):